Sutter Health will be the first healthcare system in the Sacramento area to offer SAINT, a new accelerated version of ...

The retrieval-extinction paradigm elicits a short-term fear amnesia that differs in cue specificity, timescale, and dependence on thought-control ability from the long-term amnesia believed to be ...

SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...

Patients can use the headset themselves in their homes to counteract moderate to severe depression, with what the FDA says are “modest” results.

FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).

Intuitive Surgical ISRG recently announced that it has received FDA clearance to expand the use of the da Vinci Single Port ...

With a focus on expanding access to its last mile delivery network, the United States Postal Service (USPS) said this week that shippers of all sizes will now be able to access more than 18,000 USPS ...

St. Louis County Executive Sam Page announced on Dec. 18 that he will not seek reelection when his current term expires in ...

Advanced data analytics enables companies to attack the root causes of returns. By analyzing data across product quality, ...

Midtown mental health clinic Radial Health, which offers less common treatments for mental illnesses, such as electromagnetic therapy and fast-acting medications, raised a $50 million Series A this ...

The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...

It was completely painless and so relaxing that I snoozed through the 30-minute procedure, and there’s no downtime. A course ...